{"id":7982,"date":"2025-12-22T15:31:22","date_gmt":"2025-12-22T06:31:22","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4967\/"},"modified":"2026-08-23T13:53:34","modified_gmt":"2026-08-23T04:53:34","slug":"company-4967","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4967\/","title":{"rendered":"KOBAYASHI PHARMACEUTICALS"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4967","DATE":"2025-12-26","longName":"Kobayashi Pharmaceutical Co., Ltd.","company_name_ja":"\u5c0f\u6797\u88fd\u85ac(\u682a)","fullTimeEmployees":3731,"address":"","phone":"","website":"https:\/\/www.kobayashi.co.jp","industry":"Household & Personal Products","sector":"Consumer Defensive","regularMarketPrice":5350,"financialCurrency":"","marketCap":397712,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":49.189999999999998,"epsForward":0,"bookValue":0,"totalRevenue":165742000000,"OperatingIncome":14928000000,"operatingMargins":9.0099999999999998,"NetIncome":3656000000,"profitMargins":2.21,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":1.73,"recommendationMean":3,"recommendationKey":"hold","targetMeanPrice":5496.25,"numberOfAnalystOpinions":8,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:52:50.027913\", \"ticker\": \"4967\", \"ticker_full\": \"4967.T\", \"company_name\": \"KOBAYASHI PHARMACEUTICALS\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 1, \"buy\": 1, \"hold\": 4, \"sell\": 1, \"strong_sell\": 1, \"total_analysts\": 8, \"recommendation_key\": \"hold\", \"recommendation_mean\": 3.0}, \"target_prices\": {\"has_data\": true, \"current\": 5588.0, \"high\": 6700.0, \"low\": 3950.0, \"mean\": 5496.25, \"median\": 5450.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-06\", \"eps_estimate\": 24.21, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-05-07\", \"eps_estimate\": 5.38, \"eps_actual\": 13.95, \"surprise_pct\": 159.29}, {\"date\": \"2026-02-09\", \"eps_estimate\": 81.8, \"eps_actual\": -42.41, \"surprise_pct\": -151.85}, {\"date\": \"2025-11-10\", \"eps_estimate\": 43.93, \"eps_actual\": 48.99, \"surprise_pct\": 11.52}, {\"date\": \"2025-08-04\", \"eps_estimate\": 24.03, \"eps_actual\": 20.75, \"surprise_pct\": -13.64}, {\"date\": \"2025-05-08\", \"eps_estimate\": 50.02, \"eps_actual\": 21.86, \"surprise_pct\": -56.3}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 30.78, \"institution_pct\": 24.92, \"major_holders\": [{\"label\": \"\", \"value\": 30.78}, {\"label\": \"\", \"value\": 24.92}, {\"label\": \"\", \"value\": 35.99}, {\"label\": \"\", \"value\": 82.0}], \"institutional_holders\": [{\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 735801, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.94, \"pct_change\": 0.0, \"value\": 4111655988}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 494804, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.63, \"pct_change\": 4.08, \"value\": 2764964752}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 365500, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.47, \"pct_change\": 3.89, \"value\": 2042414000}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 195100, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.25, \"pct_change\": 3.45, \"value\": 1090218800}, {\"holder\": \"SCHWAB STRATEGIC TRUST-Schwab International Equity ETF\", \"shares\": 122224, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.16, \"pct_change\": 2.84, \"value\": 682987712}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd.\", \"shares\": 113149, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.14, \"pct_change\": 2.72, \"value\": 632276612}, {\"holder\": \"VANGUARD WHITEHALL Fd.S-Vanguard Intl Dividend Appreciation Index Fd.\", \"shares\": 89020, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.11, \"pct_change\": -10.82, \"value\": 497443760}, {\"holder\": \"iShares Trust-iShares Core MSCI Total International Stock ETF\", \"shares\": 83400, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.11, \"pct_change\": 0.0, \"value\": 466039200}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Pacific Stock Index Fd.\", \"shares\": 51814, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.07, \"pct_change\": -13.81, \"value\": 289536632}, {\"holder\": \"SCHWAB STRATEGIC TRT-Schwab Fd.amental Intl Small Eqy. ETF\", \"shares\": 44629, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.06, \"pct_change\": 2.39, \"value\": 249386852}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":45,"get_dividend_history_year2":104,"get_dividend_history_year3":102,"get_dividend_history_year4":101,"get_dividend_history_year5":90,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T03:00:50.753881\", \"ticker\": \"4967\", \"ticker_full\": \"4967.T\", \"company_name\": \"KOBAYASHI PHARMACEUTICALS\", \"company_info\": {\"name_en\": \"KOBAYASHI PHARMACEUTICALS\", \"long_name\": \"Kobayashi Pharmaceutical Co., Ltd.\", \"sector\": \"Consumer Defensive\", \"industry\": \"Household & Personal Products\", \"website\": \"https:\/\/www.kobayashi.co.jp\", \"employees\": 3731, \"country\": \"Japan\", \"city\": \"Osaka\", \"address\": \"KDX Kobayashi Doshomachi Building\", \"description\": \"Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 5564.2, \"deviation\": 1.25, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 5563.8, \"deviation\": 1.26, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 5591.06, \"deviation\": 0.77, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 5508.82, \"deviation\": 2.27, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 165742000000.0, \"revenue_fmt\": \"\u00a51657\u5104\", \"gross_profit\": 84711000000.0, \"gross_profit_fmt\": \"\u00a5847\u5104\", \"operating_income\": 14928000000.0, \"operating_income_fmt\": \"\u00a5149\u5104\", \"ebit\": 3772000000.0, \"ebit_fmt\": \"\u00a538\u5104\", \"net_income\": 3656000000.0, \"net_income_fmt\": \"\u00a537\u5104\", \"eps\": 49.19, \"operating_margin\": 9.01, \"total_assets\": 275329000000.0, \"total_assets_fmt\": \"\u00a52753\u5104\", \"total_equity\": 210999000000.0, \"total_equity_fmt\": \"\u00a52110\u5104\", \"total_debt\": 678000000.0, \"total_debt_fmt\": \"\u00a57\u5104\", \"total_cash\": 62314000000.0, \"total_cash_fmt\": \"\u00a5623\u5104\", \"equity_ratio\": 76.64, \"de_ratio\": 0.0, \"current_ratio\": 2.47, \"operating_cf\": 25590000000.0, \"operating_cf_fmt\": \"\u00a5256\u5104\", \"investing_cf\": -154000000.0, \"investing_cf_fmt\": \"-\u00a52\u5104\", \"financing_cf\": -7921000000.0, \"financing_cf_fmt\": \"-\u00a579\u5104\", \"free_cf\": 11579000000.0, \"free_cf_fmt\": \"\u00a5116\u5104\", \"net_margin\": 2.21, \"roe\": 1.73, \"roa\": 1.33}, {\"year\": 2024, \"revenue\": 165600000000.0, \"revenue_fmt\": \"\u00a51656\u5104\", \"gross_profit\": 87603000000.0, \"gross_profit_fmt\": \"\u00a5876\u5104\", \"operating_income\": 24869000000.0, \"operating_income_fmt\": \"\u00a5249\u5104\", \"ebit\": 13942000000.0, \"ebit_fmt\": \"\u00a5139\u5104\", \"net_income\": 10067000000.0, \"net_income_fmt\": \"\u00a5101\u5104\", \"eps\": 135.42, \"operating_margin\": 15.02, \"total_assets\": 265368000000.0, \"total_assets_fmt\": \"\u00a52654\u5104\", \"total_equity\": 213466000000.0, \"total_equity_fmt\": \"\u00a52135\u5104\", \"total_debt\": 846000000.0, \"total_debt_fmt\": \"\u00a58\u5104\", \"total_cash\": 50873000000.0, \"total_cash_fmt\": \"\u00a5509\u5104\", \"equity_ratio\": 80.44, \"de_ratio\": 0.0, \"current_ratio\": 3.11, \"operating_cf\": 11246000000.0, \"operating_cf_fmt\": \"\u00a5112\u5104\", \"investing_cf\": -18415000000.0, \"investing_cf_fmt\": \"-\u00a5184\u5104\", \"financing_cf\": -7768000000.0, \"financing_cf_fmt\": \"-\u00a578\u5104\", \"free_cf\": -15383000000.0, \"free_cf_fmt\": \"-\u00a5154\u5104\", \"net_margin\": 6.08, \"roe\": 4.72, \"roa\": 3.79}, {\"year\": 2023, \"revenue\": 173455000000.0, \"revenue_fmt\": \"\u00a51735\u5104\", \"gross_profit\": 96375000000.0, \"gross_profit_fmt\": \"\u00a5964\u5104\", \"operating_income\": 25784000000.0, \"operating_income_fmt\": \"\u00a5258\u5104\", \"ebit\": 27588000000.0, \"ebit_fmt\": \"\u00a5276\u5104\", \"net_income\": 20338000000.0, \"net_income_fmt\": \"\u00a5203\u5104\", \"eps\": 268.16, \"operating_margin\": 14.86, \"total_assets\": 267473000000.0, \"total_assets_fmt\": \"\u00a52675\u5104\", \"total_equity\": 204816000000.0, \"total_equity_fmt\": \"\u00a52048\u5104\", \"total_debt\": 987000000.0, \"total_debt_fmt\": \"\u00a510\u5104\", \"total_cash\": 71536000000.0, \"total_cash_fmt\": \"\u00a5715\u5104\", \"equity_ratio\": 76.57, \"de_ratio\": 0.0, \"current_ratio\": 2.82, \"operating_cf\": 18360000000.0, \"operating_cf_fmt\": \"\u00a5184\u5104\", \"investing_cf\": -19576000000.0, \"investing_cf_fmt\": \"-\u00a5196\u5104\", \"financing_cf\": -19463000000.0, \"financing_cf_fmt\": \"-\u00a5195\u5104\", \"free_cf\": 4791000000.0, \"free_cf_fmt\": \"\u00a548\u5104\", \"net_margin\": 11.73, \"roe\": 9.93, \"roa\": 7.6}, {\"year\": 2022, \"revenue\": 166258000000.0, \"revenue_fmt\": \"\u00a51663\u5104\", \"gross_profit\": 92331000000.0, \"gross_profit_fmt\": \"\u00a5923\u5104\", \"operating_income\": 26674000000.0, \"operating_income_fmt\": \"\u00a5267\u5104\", \"ebit\": 27968000000.0, \"ebit_fmt\": \"\u00a5280\u5104\", \"net_income\": 20022000000.0, \"net_income_fmt\": \"\u00a5200\u5104\", \"eps\": 259.59, \"operating_margin\": 16.04, \"total_assets\": 255827000000.0, \"total_assets_fmt\": \"\u00a52558\u5104\", \"total_equity\": 197899000000.0, \"total_equity_fmt\": \"\u00a51979\u5104\", \"total_debt\": 792000000.0, \"total_debt_fmt\": \"\u00a58\u5104\", \"total_cash\": 96233000000.0, \"total_cash_fmt\": \"\u00a5962\u5104\", \"equity_ratio\": 77.36, \"de_ratio\": 0.0, \"current_ratio\": 3.34, \"operating_cf\": 31914000000.0, \"operating_cf_fmt\": \"\u00a5319\u5104\", \"investing_cf\": -14312000000.0, \"investing_cf_fmt\": \"-\u00a5143\u5104\", \"financing_cf\": -20759000000.0, \"financing_cf_fmt\": \"-\u00a5208\u5104\", \"free_cf\": 15685000000.0, \"free_cf_fmt\": \"\u00a5157\u5104\", \"net_margin\": 12.04, \"roe\": 10.12, \"roa\": 7.83}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 90.0}, {\"year\": 2023, \"amount\": 101.0}, {\"year\": 2024, \"amount\": 102.0}, {\"year\": 2025, \"amount\": 104.0}, {\"year\": 2026, \"amount\": 45.0}], \"latest\": 45.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-7982","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KOBAYASHI PHARMACEUTICALS - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4967\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4967\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4967\/\",\"name\":\"KOBAYASHI PHARMACEUTICALS - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-22T06:31:22+00:00\",\"dateModified\":\"2026-08-23T04:53:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4967\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4967\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4967\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KOBAYASHI PHARMACEUTICALS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KOBAYASHI PHARMACEUTICALS - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4967\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4967\/","url":"https:\/\/japanir.jp\/en\/company\/company-4967\/","name":"KOBAYASHI PHARMACEUTICALS - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-22T06:31:22+00:00","dateModified":"2026-08-23T04:53:34+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4967\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4967\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4967\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"KOBAYASHI PHARMACEUTICALS"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/7982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=7982"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=7982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}